239 related articles for article (PubMed ID: 34185288)
1. Esophageal Tumor Microenvironment.
Nienhüser H; Wirsik N; Schmidt T
Adv Exp Med Biol; 2020; 1296():103-116. PubMed ID: 34185288
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
Yetkin-Arik B; Kastelein AW; Klaassen I; Jansen CHJR; Latul YP; Vittori M; Biri A; Kahraman K; Griffioen AW; Amant F; Lok CAR; Schlingemann RO; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188446. PubMed ID: 33058997
[TBL] [Abstract][Full Text] [Related]
3. The tumor microenvironment in esophageal cancer.
Lin EW; Karakasheva TA; Hicks PD; Bass AJ; Rustgi AK
Oncogene; 2016 Oct; 35(41):5337-5349. PubMed ID: 26923327
[TBL] [Abstract][Full Text] [Related]
4. Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions.
Sattiraju A; Mintz A
Adv Exp Med Biol; 2019; 1147():65-91. PubMed ID: 31147872
[TBL] [Abstract][Full Text] [Related]
5. IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
Karakasheva TA; Lin EW; Tang Q; Qiao E; Waldron TJ; Soni M; Klein-Szanto AJ; Sahu V; Basu D; Ohashi S; Baba K; Giaccone ZT; Walker SR; Frank DA; Wileyto EP; Long Q; Dunagin MC; Raj A; Diehl JA; Wong KK; Bass AJ; Rustgi AK
Cancer Res; 2018 Sep; 78(17):4957-4970. PubMed ID: 29976575
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of pancreatic cancer.
Sunami Y; Kleeff J
Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
[TBL] [Abstract][Full Text] [Related]
8. Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.
Heidari P; Esfahani SA; Turker NS; Wong G; Wang TC; Rustgi AK; Mahmood U
J Nucl Med; 2015 Aug; 56(8):1246-51. PubMed ID: 26069303
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
Shafqat A; Omer MH; Ahmed EN; Mushtaq A; Ijaz E; Ahmed Z; Alkattan K; Yaqinuddin A
Front Immunol; 2023; 14():1200941. PubMed ID: 37520562
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer.
Liang F; Xu H; Cheng H; Zhao Y; Zhang J
Cancer Gene Ther; 2023 Nov; 30(11):1443-1455. PubMed ID: 37537209
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment of Esophageal Cancer.
Schiffmann LM; Plum PS; Fuchs HF; Babic B; Bruns CJ; Schmidt T
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572905
[TBL] [Abstract][Full Text] [Related]
12. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human umbilical vein endothelial cells.
Jin G; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Zhang Y; Lu J; Dong Z
Oncol Rep; 2016 Jul; 36(1):155-64. PubMed ID: 27222202
[TBL] [Abstract][Full Text] [Related]
14.
Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
[No Abstract] [Full Text] [Related]
15. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs contribution in tumor microenvironment of esophageal cancer.
Nouraee N; Khazaei S; Vasei M; Razavipour SF; Sadeghizadeh M; Mowla SJ
Cancer Biomark; 2016; 16(3):367-76. PubMed ID: 26889983
[TBL] [Abstract][Full Text] [Related]
17. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
[TBL] [Abstract][Full Text] [Related]
18. Immune determinants of Barrett's progression to esophageal adenocarcinoma.
Lagisetty KH; McEwen DP; Nancarrow DJ; Schiebel JG; Ferrer-Torres D; Ray D; Frankel TL; Lin J; Chang AC; Kresty LA; Beer DG
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33290281
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
Schmitz S; Machiels JP
Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
[Next] [New Search]